266 related articles for article (PubMed ID: 27481036)
41. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.
Tomkovich S; Lesniak NA; Li Y; Bishop L; Fitzgerald MJ; Schloss PD
mSphere; 2019 Nov; 4(6):. PubMed ID: 31748246
[TBL] [Abstract][Full Text] [Related]
42. Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection.
Lin CY; Cheng HT; Kuo CJ; Lee YS; Sung CM; Keidan M; Rao K; Kao JY; Hsieh SY
Microbiol Spectr; 2022 Aug; 10(4):e0048622. PubMed ID: 35863023
[TBL] [Abstract][Full Text] [Related]
43. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
44. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
45. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
[TBL] [Abstract][Full Text] [Related]
46. Missed diagnosis of Clostridium difficile infection; a prospective evaluation of unselected stool samples.
Reigadas E; Alcalá L; Marín M; Burillo A; Muñoz P; Bouza E
J Infect; 2015 Mar; 70(3):264-72. PubMed ID: 25452039
[TBL] [Abstract][Full Text] [Related]
47. Factors Predicting Recurrence of Clostridium difficile Infection (CDI) in Hospitalized Patients: Retrospective Study of More Than 2000 Patients.
Abdelfatah M; Nayfe R; Nijim A; Enriquez K; Ali E; Watkins RR; Kandil H
J Investig Med; 2015 Jun; 63(5):747-51. PubMed ID: 25871748
[TBL] [Abstract][Full Text] [Related]
48. The tipping point: patients predisposed to Clostridium difficile infection and a hospital antimicrobial stewardship programme.
Stites SD; Cooblall CA; Aronovitz J; Singletary SB; Micklow K; Sjeime M
J Hosp Infect; 2016 Nov; 94(3):242-248. PubMed ID: 27742079
[TBL] [Abstract][Full Text] [Related]
49. Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home.
Rodriguez C; Taminiau B; Korsak N; Avesani V; Van Broeck J; Brach P; Delmée M; Daube G
BMC Microbiol; 2016 Oct; 16(1):229. PubMed ID: 27716140
[TBL] [Abstract][Full Text] [Related]
50. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
51. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
King RN; Lager SL
Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
[TBL] [Abstract][Full Text] [Related]
52. Microbiome profile and calprotectin levels as markers of risk of recurrent
Vázquez-Cuesta S; Lozano García N; Fernández AI; Olmedo M; Kestler M; Alcalá L; Marín M; Bermejo J; Díaz FF; Muñoz P; Bouza E; Reigadas E
Front Cell Infect Microbiol; 2023; 13():1237500. PubMed ID: 37780848
[TBL] [Abstract][Full Text] [Related]
53. Toxin B PCR cycle threshold as a predictor of poor outcome of Clostridium difficile infection: a derivation and validation cohort study.
Reigadas E; Alcalá L; Valerio M; Marín M; Martin A; Bouza E
J Antimicrob Chemother; 2016 May; 71(5):1380-5. PubMed ID: 26869691
[TBL] [Abstract][Full Text] [Related]
54. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
[TBL] [Abstract][Full Text] [Related]
55. Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.
Peretz A; Tkhawkho L; Pastukh N; Brodsky D; Halevi CN; Nitzan O
BMC Infect Dis; 2016 Jun; 16():309. PubMed ID: 27334992
[TBL] [Abstract][Full Text] [Related]
56. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Lv Z; Peng G; Liu W; Xu H; Su J
Antimicrob Agents Chemother; 2015 Jul; 59(7):3726-35. PubMed ID: 25824219
[TBL] [Abstract][Full Text] [Related]
57. Decreased Fecal Bacterial Diversity and Altered Microbiome in Children Colonized With Clostridium difficile.
Chen LA; Hourigan SK; Grigoryan Z; Gao Z; Clemente JC; Rideout JR; Chirumamilla S; Rabidazeh S; Saeed S; Elson CO; Oliva-Hemker M; Blaser MJ; Sears CL
J Pediatr Gastroenterol Nutr; 2019 Apr; 68(4):502-508. PubMed ID: 30540709
[TBL] [Abstract][Full Text] [Related]
58. Disordered Intestinal Microbial Communities During
Chen Y; Lv T; Yan D; Zheng L; Zheng B; Wang J; Gu S; Li L
Front Cell Infect Microbiol; 2022; 12():825189. PubMed ID: 35433508
[TBL] [Abstract][Full Text] [Related]
59. Influence of cohorting patients with Clostridium difficile infection on risk of symptomatic recurrence.
Islam J; Cheek E; Navani V; Rajkumar C; Cohen J; Llewelyn MJ
J Hosp Infect; 2013 Sep; 85(1):17-21. PubMed ID: 23910403
[TBL] [Abstract][Full Text] [Related]
60. Environmental Contamination in Households of Patients with Recurrent Clostridium difficile Infection.
Shaughnessy MK; Bobr A; Kuskowski MA; Johnston BD; Sadowsky MJ; Khoruts A; Johnson JR
Appl Environ Microbiol; 2016 May; 82(9):2686-2692. PubMed ID: 26921425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
